Advice

Following an abbreviated submission

tobramycin 300mg/4ml nebuliser solution (Bramitob) is accepted for use in NHS Scotland for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

This preparation offers an alternative to an existing nebuliser solution at a lower cost per dose.

Download detailed advice53KB (PDF)

Download

Medicine details

Medicine name:
tobramycin (Bramitob)
SMC ID:
314/06
Indication:
Chronic pulmonary infection
Pharmaceutical company
Trinity Chiesi Pharmaceuticals
BNF chapter
Infections
Submission type
Abbreviated
Status
Accepted
Date advice published:
09 March 2009